Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vaginal Candidiasis
Conditions
Vaginal Candidiasis, Bacterial Vaginosis, Trichomonal Vaginitis
Trial Timeline
Oct 1, 2010 → Apr 1, 2015
NCT ID
NCT01335373About Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276) is a pre-clinical stage product being developed by Bayer for Vaginal Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT01335373. Target conditions include Vaginal Candidiasis, Bacterial Vaginosis, Trichomonal Vaginitis.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01335373 | Pre-clinical | Completed |
Competing Products
19 competing products in Vaginal Candidiasis